Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Approves First Drug for Advanced Macular Degeneration

Teprotumumab reduces inflammation, which causes damage in the eye that leads to progressive central vision loss.

Goggles
Getty Images

Macular degeneration is caused by the deterioration of the macula, a small part of the retina that is responsible for sharp, central vision. It’s most common in older adults and can lead to severe vision loss or blindness. According to a recent CBS News article, the FDA has approved the first and only drug for the treatment of advanced macular degeneration. The drug, teprotumumab, is administered intravenously and has proven effective in clinical trials, with some patients experiencing significant improvement in vision.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report